E2F1 and central nervous system cancer: Besides, the positive correlation between Pontin and six E2F1 targets (AURKA, CDK1, CDK4, CCNA2, CCNB2, E2F8) assessed by GEPIA in glioma further supported the positive regulation of E2F1 targets expressions by Pontin (Supplementary Fig. S3).